Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2013-12-11 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONTREUIL-SUR-ILLE (35440), Ille-et-Vilaine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE L'ILLE : revenue, balance sheet and financial ratios
PHARMACIE DE L'ILLE is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTREUIL-SUR-ILLE (35440),
this company of category PME
shows in 2022 a revenue of 2.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'ILLE (SIREN 799235148)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 533 275 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
206 870 €
102 390 €
250 793 €
152 369 €
127 334 €
145 575 €
148 940 €
146 961 €
-34 836 €
EBITDA
N/C
N/C
357 195 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
9.9%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE L'ILLE generates positive net income of 207 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
206 870 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
49.294%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
61.428%
Solvency indicators evolution PHARMACIE DE L'ILLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
552.93
367.995
256.524
208.631
152.097
129.832
92.25
70.162
49.294
Financial autonomy
13.867
18.998
25.077
28.826
36.206
40.037
46.436
52.585
61.428
Repayment capacity
None
None
None
None
None
None
4.933
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
10.619%
None%
None%
Sector positioning
Debt ratio
49.292024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-10 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE L'ILLE (49.29) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
61.43%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+16 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE L'ILLE (61.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.93 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DE L'ILLE (4.93) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 1203.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1203.263
Liquidity indicators evolution PHARMACIE DE L'ILLE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
210.688
192.867
186.386
171.371
213.88
270.461
225.503
191.493
1203.263
Interest coverage
None
None
None
None
None
None
3.834
None
None
Sector positioning
Liquidity ratio
1203.262024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent+16 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE L'ILLE (1203.26) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.83x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Good
In 2022, the interest coverage of PHARMACIE DE L'ILLE (3.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE L'ILLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
308 173 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
45
0
0
Customer payment term (days)
0
0
0
0
0
0
1
0
0
Supplier payment term (days)
0
0
0
0
0
0
49
0
0
Positioning of PHARMACIE DE L'ILLE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE L'ILLE is estimated at
2 888 058 €
(range 2 011 198€ - 4 320 700€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2011k€2888k€4320k€
2 888 058 €Range: 2 011 198€ - 4 320 700€
NAF 5 année 2024
Valuation method used
Net Income Multiple
206 870 €
×
14.0x
=2 888 058 €
Range: 2 011 198€ - 4 320 700€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'ILLE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'ILLE
What is the revenue of PHARMACIE DE L'ILLE ?
The revenue of PHARMACIE DE L'ILLE in 2022 is 2.5 M€.
Is PHARMACIE DE L'ILLE profitable?
Yes, PHARMACIE DE L'ILLE generated a net profit of 207 k€ in 2024.
Where is the headquarters of PHARMACIE DE L'ILLE ?
The headquarters of PHARMACIE DE L'ILLE is located in MONTREUIL-SUR-ILLE (35440), in the department Ille-et-Vilaine.
Where to find the tax return of PHARMACIE DE L'ILLE ?
The tax return of PHARMACIE DE L'ILLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'ILLE operate?
PHARMACIE DE L'ILLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart